Trial of Autologous, Hapten-Modified Vaccine, OVAX, in Patients With Relapsed Stage III or IV Ovarian Cancer

NCT00660101 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Adenocarcinoma of the Ovary

Interventions

BIOLOGICAL: OVax: Autologous, DNP-Modified Ovarian Cancer Vaccine

Sponsor

AVAX Technologies